Inmode Ltd (INMD)

$14.31 +0.06 (0.42%)
Market Cap 931.70M
Revenue (ttm) 394.82M
Net Income (ttm) 181.28M
EPS (ttm) N/A
PE Ratio 9.37
Forward PE 9.02
Profit Margin 45.91%
Debt to Equity Ratio 0.00
Volume 260,563
Avg Vol 1,354,998
Day's Range N/A - N/A
Shares Out 63.21M
Stochastic %K 1%
Beta 1.95
Analysts Sell
Price Target $17.05

Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well a...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 909 6313
Address:
Tavor Building, Sha’ar Yokneam PO Box 533, Yokne'am, Israel
Nova_82
Nova_82 Jul. 16 at 3:09 PM
$INMD ⁨⁩ ⁨WKSP is waking up. Over the past few hours the price dipped to $3.83 before rebounding sharply to $3.87-3.90 on rising volume (100-500‑lot trades), signaling that big players are stepping in and the market is gearing up for a fresh rally. According to the latest analyst survey: 33% rate it a Strong Buy and 67% a Buy, with an average price target of $10.33. At today, the upside potential exceeds +150%. Holding the $3.80-3.90 zone will lay a solid foundation for a breakout above $4.00 and a push toward those targets⁩
0 · Reply
findingthestock
findingthestock Jul. 16 at 3:09 AM
$INMD EVERYONE WHO thought this was a good investment is DOWN and losing If you bought at 50,40,30,20,15 Management is horrible Large shareholder Doma wants them removed This is very bad sign and institution will start selling more and more which will cause the stock to sink below $10 to new lows https://www.prnewswire.com/news-releases/doma-perpetual-sends-letter-urging-board-of-directors-of-inmode-ltd-to-resume-share-repurchase-program-302451097.html DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program
0 · Reply
Azereke
Azereke Jul. 15 at 5:32 PM
$INMD people are confused this company is not a growth stock its a cash generating value stock and with liquid/eps/roe this company is a juicy as it gets
1 · Reply
_StockFox_
_StockFox_ Jul. 15 at 1:47 AM
Few shares a day..... $CIG $INMD $VMEO $TZOO
0 · Reply
sellthetop
sellthetop Jul. 11 at 5:07 PM
$INMD very poorly run company.
1 · Reply
findingthestock
findingthestock Jul. 11 at 3:05 PM
$INMD Stock is sinking because of growth and sales issue Decline decline and revised guidance No new stock buybacks Large shareholders DOMA want management removed Stock is heading down this is bad real bad
0 · Reply
JarvisFlow
JarvisFlow Jul. 11 at 2:32 PM
Canaccord Genuity has adjusted their stance on InMode ( $INMD ), setting the rating to Hold with a target price of 15.
0 · Reply
findingthestock
findingthestock Jul. 11 at 6:22 AM
$INMD this company and management is so predictable and no return value for shareholders GROWTH CHALLENGES talk to aesthetic doctors, the new devices are not worth the investment. That’s why sales decline each quarter Due to market weakness and U.S. economic uncertainty, InMode has decreased its full-year 2025 revenue guidance to $365-375 million, down from the previous guidance of $395-405 million. The company will discuss detailed Q2 2025 results in a conference call scheduled for July 30, 2025.
0 · Reply
tknofile
tknofile Jul. 10 at 2:23 PM
$INMD guidance lowered again...probably hold this thing and wait to trim position
1 · Reply
Kinoko007
Kinoko007 Jul. 10 at 1:52 PM
$INMD down barely 1pc after the revision is a clear sign of how cheap this is and how much has already been priced in. Retaol investors are always too late to buy in good opportunities and equally latento sell out overvalued ones.
1 · Reply
Latest News on INMD
InMode: Margin Pressure, But Optionality Makes It Worth A Look

Jul 12, 2025, 8:08 AM EDT - 4 days ago

InMode: Margin Pressure, But Optionality Makes It Worth A Look

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

Jul 10, 2025, 7:00 AM EDT - 6 days ago

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

May 28, 2025, 8:30 AM EDT - 7 weeks ago

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

May 9, 2025, 8:22 AM EDT - 2 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

InMode to Present at Upcoming Investor Conferences and Events

May 7, 2025, 8:30 AM EDT - 2 months ago

InMode to Present at Upcoming Investor Conferences and Events

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

May 6, 2025, 8:03 AM EDT - 2 months ago

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade)

Apr 29, 2025, 7:00 AM EDT - 2 months ago

InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade)

InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade)

Apr 29, 2025, 1:52 AM EDT - 2 months ago

InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade)

Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City

Apr 28, 2025, 1:41 PM EDT - 2 months ago

Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City

InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 11:53 AM EDT - 2 months ago

InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

Apr 28, 2025, 7:00 AM EDT - 2 months ago

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease

InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)

Apr 3, 2025, 4:26 AM EDT - 3 months ago

InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)

InMode to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 26, 2025, 8:30 AM EDT - 4 months ago

InMode to Present at the 24th Annual Needham Virtual Healthcare Conference

InMode Responds to Doma Perpetual's Letters

Mar 6, 2025, 7:30 AM EST - 4 months ago

InMode Responds to Doma Perpetual's Letters

InMode to Present at Upcoming Investor Conferences

Mar 3, 2025, 8:30 AM EST - 4 months ago

InMode to Present at Upcoming Investor Conferences

InMode: Plastic Surgery Boom, Cash Flow, And Cheap

Feb 10, 2025, 1:14 AM EST - 5 months ago

InMode: Plastic Surgery Boom, Cash Flow, And Cheap

InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 9:08 AM EST - 5 months ago

InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

Feb 4, 2025, 7:00 AM EST - 5 months ago

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Feb 3, 2025, 8:30 AM EST - 5 months ago

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

InMode: A Clear Bargain With Unique Risks

Jan 28, 2025, 9:32 AM EST - 6 months ago

InMode: A Clear Bargain With Unique Risks

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

Jan 16, 2025, 7:00 AM EST - 6 months ago

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

Jan 15, 2025, 8:05 AM EST - 6 months ago

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

InMode: Clearly, I Was Too Optimistic (Rating Downgrade)

Jan 10, 2025, 6:07 AM EST - 6 months ago

InMode: Clearly, I Was Too Optimistic (Rating Downgrade)

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

Jan 8, 2025, 7:00 AM EST - 6 months ago

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

InMode: Product Origination And Undervaluation Make The Stock A Buy

Dec 12, 2024, 1:17 AM EST - 7 months ago

InMode: Product Origination And Undervaluation Make The Stock A Buy

InMode: $25/Share Is Closer Than You Think

Nov 5, 2024, 9:43 AM EST - 9 months ago

InMode: $25/Share Is Closer Than You Think

InMode: A Deep Dive After Q3 Earnings

Oct 31, 2024, 12:16 PM EDT - 9 months ago

InMode: A Deep Dive After Q3 Earnings

InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 11:33 AM EDT - 9 months ago

InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

Oct 30, 2024, 7:00 AM EDT - 9 months ago

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

Oct 24, 2024, 7:03 AM EDT - 9 months ago

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

Oct 10, 2024, 7:00 AM EDT - 9 months ago

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

Stock Picks From Seeking Alpha's September 2024 New Analysts

Oct 4, 2024, 8:00 AM EDT - 10 months ago

Stock Picks From Seeking Alpha's September 2024 New Analysts

AME CCL CRWD CUK DVN EGO EMR

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

Oct 1, 2024, 7:00 AM EDT - 10 months ago

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

InMode Offers High Risk-Reward Opportunity Amid New Products And Rate Cuts (Rating Upgrade)

Sep 19, 2024, 7:14 AM EDT - 10 months ago

InMode Offers High Risk-Reward Opportunity Amid New Products And Rate Cuts (Rating Upgrade)

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

Sep 10, 2024, 7:00 AM EDT - 11 months ago

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

InMode Stock: An Inverse Bubble Caused By Short-Term Trouble

Sep 6, 2024, 4:38 AM EDT - 11 months ago

InMode Stock: An Inverse Bubble Caused By Short-Term Trouble

InMode to Present at 2024 Baird Global Healthcare Conference

Sep 4, 2024, 8:30 AM EDT - 11 months ago

InMode to Present at 2024 Baird Global Healthcare Conference

InMode Ltd. (INMD) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 11:19 AM EDT - 1 year ago

InMode Ltd. (INMD) Q2 2024 Earnings Call Transcript

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M

Aug 1, 2024, 7:00 AM EDT - 1 year ago

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M

InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform

Jul 31, 2024, 8:03 AM EDT - 1 year ago

InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform

DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer

Jul 25, 2024, 8:15 AM EDT - 1 year ago

DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer

Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling

Jul 17, 2024, 8:03 AM EDT - 1 year ago

Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling

InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024

Jul 11, 2024, 8:30 AM EDT - 1 year ago

InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024

InMode: Reversing Previous Shareholder Dilution With Buybacks

Jun 13, 2024, 11:49 AM EDT - 1 year ago

InMode: Reversing Previous Shareholder Dilution With Buybacks

InMode to Present at Jefferies Healthcare Conference

May 16, 2024, 8:00 AM EDT - 1 year ago

InMode to Present at Jefferies Healthcare Conference

InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand

May 8, 2024, 8:03 AM EDT - 1 year ago

InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand

InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M;

May 2, 2024, 7:00 AM EDT - 1 year ago

InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M;

IMPORTANT DEADLINE TODAY: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm

Apr 15, 2024, 9:00 AM EDT - 1 year ago

IMPORTANT DEADLINE TODAY: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the Firm

Nova_82
Nova_82 Jul. 16 at 3:09 PM
$INMD ⁨⁩ ⁨WKSP is waking up. Over the past few hours the price dipped to $3.83 before rebounding sharply to $3.87-3.90 on rising volume (100-500‑lot trades), signaling that big players are stepping in and the market is gearing up for a fresh rally. According to the latest analyst survey: 33% rate it a Strong Buy and 67% a Buy, with an average price target of $10.33. At today, the upside potential exceeds +150%. Holding the $3.80-3.90 zone will lay a solid foundation for a breakout above $4.00 and a push toward those targets⁩
0 · Reply
findingthestock
findingthestock Jul. 16 at 3:09 AM
$INMD EVERYONE WHO thought this was a good investment is DOWN and losing If you bought at 50,40,30,20,15 Management is horrible Large shareholder Doma wants them removed This is very bad sign and institution will start selling more and more which will cause the stock to sink below $10 to new lows https://www.prnewswire.com/news-releases/doma-perpetual-sends-letter-urging-board-of-directors-of-inmode-ltd-to-resume-share-repurchase-program-302451097.html DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program
0 · Reply
Azereke
Azereke Jul. 15 at 5:32 PM
$INMD people are confused this company is not a growth stock its a cash generating value stock and with liquid/eps/roe this company is a juicy as it gets
1 · Reply
_StockFox_
_StockFox_ Jul. 15 at 1:47 AM
Few shares a day..... $CIG $INMD $VMEO $TZOO
0 · Reply
sellthetop
sellthetop Jul. 11 at 5:07 PM
$INMD very poorly run company.
1 · Reply
findingthestock
findingthestock Jul. 11 at 3:05 PM
$INMD Stock is sinking because of growth and sales issue Decline decline and revised guidance No new stock buybacks Large shareholders DOMA want management removed Stock is heading down this is bad real bad
0 · Reply
JarvisFlow
JarvisFlow Jul. 11 at 2:32 PM
Canaccord Genuity has adjusted their stance on InMode ( $INMD ), setting the rating to Hold with a target price of 15.
0 · Reply
findingthestock
findingthestock Jul. 11 at 6:22 AM
$INMD this company and management is so predictable and no return value for shareholders GROWTH CHALLENGES talk to aesthetic doctors, the new devices are not worth the investment. That’s why sales decline each quarter Due to market weakness and U.S. economic uncertainty, InMode has decreased its full-year 2025 revenue guidance to $365-375 million, down from the previous guidance of $395-405 million. The company will discuss detailed Q2 2025 results in a conference call scheduled for July 30, 2025.
0 · Reply
tknofile
tknofile Jul. 10 at 2:23 PM
$INMD guidance lowered again...probably hold this thing and wait to trim position
1 · Reply
Kinoko007
Kinoko007 Jul. 10 at 1:52 PM
$INMD down barely 1pc after the revision is a clear sign of how cheap this is and how much has already been priced in. Retaol investors are always too late to buy in good opportunities and equally latento sell out overvalued ones.
1 · Reply
R33dh
R33dh Jul. 10 at 1:23 PM
$INMD Sorry to anyone still holding this POS.
1 · Reply
TheBuyHighSellLow
TheBuyHighSellLow Jul. 10 at 12:33 PM
$INMD So happy that I'm out here! The decline will continue.
0 · Reply
meeepah
meeepah Jul. 10 at 11:20 AM
$INMD still sucks I see
0 · Reply
DonCorleone77
DonCorleone77 Jul. 10 at 11:19 AM
$INMD InMode cuts FY25 revenue guidance from $395M-$405M to $365M-$375M
0 · Reply
DonCorleone77
DonCorleone77 Jul. 10 at 11:18 AM
$INMD InMode sees Q2 revenue between $95.4M-$95.5M, below consensus of $98.45M
0 · Reply
StardustTrader
StardustTrader Jul. 9 at 3:01 PM
$INMD added
1 · Reply
Awiz2
Awiz2 Jul. 9 at 11:41 AM
$INMD $20+
0 · Reply
Shortsnightmare
Shortsnightmare Jul. 7 at 4:45 PM
$INMD Israel has eliminated all tariffs on US imports so hopefully the US eliminates the 10 pct tariff on Israel. Bibi and Trump meeting tonight in Washington. INMD has fully reflected the 10 pct tariff in their margin guidance so its removal would be a big win…..
0 · Reply
findingthestock
findingthestock Jul. 7 at 4:24 PM
$INMD Every quarter the sales numbers decrease and they give a grim outlook Their words “no light at the end of the tunnel” North America is their money maker and it’s causing the revised guidance Need more positive news and catalysts to get this moving
0 · Reply
_StockFox_
_StockFox_ Jul. 6 at 4:46 AM
$INMD 🦊Buyer Here around $15 or lower....a lot better than buying at $30-$40. This stock has tangible value, a lot don't lol. CHEAP HERE! The market participation tells you all you need to know. Technical setup: 50M float. Price is pressing toward the lower bound of a multi-month base after an uptrend that’s cooled off. Volatility has dropped which in my opinion signals: • Exhaustion of sellers • Increase in passive accumulation • Or a shift in market participant structure 📉 HUGE gap to fill with a catalyst/volume 📊What I like about the fundamentals: 4 out of the last 5 years of net income growth and they are consistent profitability. 2024 saw a plateau of net income growth, however, not a collapse. $155M in cash. NO DEBT. You saw what I said about Warren Buffet in my last post. Buyback potential. Free cash flow positive for 5+ years, CONSISTENTLY. If the market regains interest, this could be one of those quiet runners that rerates fast considering the float.
1 · Reply
newscatch
newscatch Jul. 5 at 10:35 PM
$INMD https://youtu.be/A64Mkxw1rEY?feature=shared
0 · Reply
WeeklyOptionsTrading
WeeklyOptionsTrading Jul. 5 at 12:58 PM
$INMD big gains coming
0 · Reply